5 results for author:"Morel J.C." in Literature citations
·
| Signal transduction pathways involved in rheumatoid arthritis synovial fibroblast interleukin-18-induced vascular cell adhesion molecule-1 expression. Morel J.C., Park C.C., Zhu K., Kumar P., Ruth J.H., Koch A.E.
J. Biol. Chem. 277:34679-34691(2002) · Mapped (6) |
| Interleukin-18 induces rheumatoid arthritis synovial fibroblast CXC chemokine production through NFkappaB activation. Morel J.C., Park C.C., Kumar P., Koch A.E.
Lab. Invest. 81:1371-1383(2001) · Mapped (5) |
| A novel role for interleukin-18 in adhesion molecule induction through NF kappa B and phosphatidylinositol (PI) 3-kinase-dependent signal transduction pathways. Morel J.C., Park C.C., Woods J.M., Koch A.E.
J. Biol. Chem. 276:37069-37075(2001) · Mapped (5) |
| Evidence of IL-18 as a novel angiogenic mediator. Park C.C., Morel J.C., Amin M.A., Connors M.A., Harlow L.A., Koch A.E.
J. Immunol. 167:1644-1653(2001) · Mapped (8) |
| Fractalkine, a novel chemokine in rheumatoid arthritis and in rat adjuvant-induced arthritis. Ruth J.H., Volin M.V., Haines G.K., Woodruff D.C., Katschke K.J. Jr., Woods J.M., Park C.C., Morel J.C., Koch A.E.
Arthritis Rheum. 44:1568-1581(2001) · Mapped (3) |
·
